机构:[1]Institute for Breast Health Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu,Sichuan 610041, China四川大学华西医院[2]Department of Biotherapy, West China Hospital and State Key Laboratory of Biotherapy, Sichuan University, Chengdu,Sichuan 610041, China四川大学华西医院[3]Department of Pancreatic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China四川大学华西医院[4]College of Chemical Engineering, Shijiazhuang University, Shijiazhuang, Hebei 050035, China
National Key Research and Development Program of China (no.
2022YFC2504700 [2022YFC2504703]), National Natural Science Foundation of China (nos.
82172634, 22105137, and 81902685), Key Program of the Science and Technology Bureau of Sichuan, China (nos. 2021YFSY0007 and 2020YFS0204), 1.3.5 project for disciplines of excellence,
West China Hospital, Sichuan University (no. ZYYC20013), and Doctoral Research Foundation of Shijiazhuang University, China (no. 22BS008)
语种:
外文
PubmedID:
第一作者:
第一作者机构:[1]Institute for Breast Health Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu,Sichuan 610041, China
共同第一作者:
通讯作者:
通讯机构:[1]Institute for Breast Health Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu,Sichuan 610041, China
推荐引用方式(GB/T 7714):
Liu Xiaowei,Song Jinen,Liu Xinyu,et al.Protocol for identifying immune checkpoint on circulating tumor cells of human pancreatic ductal adenocarcinoma by single-cell RNA sequencing[J].STAR protocols.2023,4(3):102539.doi:10.1016/j.xpro.2023.102539.
APA:
Liu Xiaowei,Song Jinen,Liu Xinyu,Zhang Hao,Wang Xueyan...&Shi Hubing.(2023).Protocol for identifying immune checkpoint on circulating tumor cells of human pancreatic ductal adenocarcinoma by single-cell RNA sequencing.STAR protocols,4,(3)
MLA:
Liu Xiaowei,et al."Protocol for identifying immune checkpoint on circulating tumor cells of human pancreatic ductal adenocarcinoma by single-cell RNA sequencing".STAR protocols 4..3(2023):102539